Clinical Trials Directory

Trials / Completed

CompletedNCT03475641

Femoral Nerve Blockade in Endovenous Laser

Femoral Nerve Blockade in Endovenous Laser During Varicose Vein Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Varicose veins affect a majority of adult population in the western world. They decrease quality of life and may also cause venous ulcers. Therefore varicose vein treatments are justified. Currently endovenous thermal ablation is a treatment of choice for varicose veins. At the outpatient setting, however, treating both limbs at the same time may be painful to the patient especially, if simultaneous phlebectomies are performed. The study aims to evaluate, if femoral nerve blockade can significantly decrease pain during the procedure without prolonging the stay in the hospital.

Detailed description

Varicose veins affect a majority of adult population in the western world. They decrease quality of life and may also cause venous ulcers. Therefore varicose vein treatments are justified. Thanks to technical advancement open surgery has been replaced By endovenous means. Currently endovenous thermal ablation is a golden standard for main trunk disease. For efficient patient and procedure flow majority of thermal ablations are performed at the outpatient setting. However, if patient is suffering from significant varicose veins, treating both legs, may be unpleasant to the patient. Aim of the study is, whether addition of femoral nerve blockade to the tumescent anesthesia can decrease pain during the procedure without prolonging the stay in the hospital.

Conditions

Interventions

TypeNameDescription
DRUGFemoral nerve blockadeThe femoral nerve blockade with lidocain is combined to the tumescent anesthesia.
PROCEDUREThe current standard treatmentTumescent anesthesia.

Timeline

Start date
2017-03-13
Primary completion
2019-10-15
Completion
2021-12-31
First posted
2018-03-23
Last updated
2022-08-09

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT03475641. Inclusion in this directory is not an endorsement.